Orchard raises US$150 million to expand after GSK gene therapy deal


Anglo-American biotech company Orchard Therapeutics has raised a further US$150 million to fund its work in gene therapy, building on earlier fundraisings worth more than US$140 million. LONDON: Anglo-American biotech company Orchard Therapeutics has raised a further US$150 million to fund its work in gene therapy, building on earlier fundraisings worth more than US$140 million.



from Biotech News